The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies
Abstract Anecdotal evidence suggests that community infection control measures during the COVID-19 outbreak have modified the number and natural history of acute surgical inflammatory processes (ASIP—appendicitis, cholecystitis, diverticulitis and perianal abscesses) admissions. This study aims to e...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d7e36ab7e294d74a8f63bb837397e85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:2d7e36ab7e294d74a8f63bb837397e85 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:2d7e36ab7e294d74a8f63bb837397e852021-12-02T18:37:09ZThe SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies10.1038/s41598-021-98878-w2045-2322https://doaj.org/article/2d7e36ab7e294d74a8f63bb837397e852021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98878-whttps://doaj.org/toc/2045-2322Abstract Anecdotal evidence suggests that community infection control measures during the COVID-19 outbreak have modified the number and natural history of acute surgical inflammatory processes (ASIP—appendicitis, cholecystitis, diverticulitis and perianal abscesses) admissions. This study aims to evaluate the impact of the COVID-19 pandemic on the presentation and treatment ASIP and quantify the effect of COVID-19 infection on the outcomes of ASIP patients. This was a multicentre, comparative study, whereby ASIP cases from 2019, 2020 and 2021 (March 14th to May 2nd) were analyzed. Data regarding patient and disease characteristics as well as outcomes, were collected from sixteen centres in Madrid, and one in Seville (Spain). The number of patients treated for ASIP in 2019 was 822 compared to 521 in 2020 and 835 in 2021. This 1/3rd reduction occurs mainly in patients with mild cases, while the number of severe cases was similar. Surgical standards suffered a step back during the first wave: Lower laparoscopic approach and longer length of stay. We also found a more conservative approach to the patients this year, non-justified by clinical circumstances. Luckily these standards improved again in 2021. The positive COVID-19 status itself did not have a direct impact on mortality. Strikingly, none of the 33 surgically treated COVID positive patients during both years died postoperatively. This is an interesting finding which, if confirmed through future research with a larger sample size of COVID-19 positive patients, can expedite the recovery phase of acute surgical services.H. GuadalajaraJ. L. Muñoz de NovaM. YiasemidouM. Recarte RicoL. D. JuezJ. García SeptiemP. Galindo JaraM. García VirostaE. Lobo MartínezE. Martín-PérezS. Fernandez GonzalezO. Lopez-FernandezD. García-OlmoPIACO Collaboration GroupNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q H. Guadalajara J. L. Muñoz de Nova M. Yiasemidou M. Recarte Rico L. D. Juez J. García Septiem P. Galindo Jara M. García Virosta E. Lobo Martínez E. Martín-Pérez S. Fernandez Gonzalez O. Lopez-Fernandez D. García-Olmo PIACO Collaboration Group The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
description |
Abstract Anecdotal evidence suggests that community infection control measures during the COVID-19 outbreak have modified the number and natural history of acute surgical inflammatory processes (ASIP—appendicitis, cholecystitis, diverticulitis and perianal abscesses) admissions. This study aims to evaluate the impact of the COVID-19 pandemic on the presentation and treatment ASIP and quantify the effect of COVID-19 infection on the outcomes of ASIP patients. This was a multicentre, comparative study, whereby ASIP cases from 2019, 2020 and 2021 (March 14th to May 2nd) were analyzed. Data regarding patient and disease characteristics as well as outcomes, were collected from sixteen centres in Madrid, and one in Seville (Spain). The number of patients treated for ASIP in 2019 was 822 compared to 521 in 2020 and 835 in 2021. This 1/3rd reduction occurs mainly in patients with mild cases, while the number of severe cases was similar. Surgical standards suffered a step back during the first wave: Lower laparoscopic approach and longer length of stay. We also found a more conservative approach to the patients this year, non-justified by clinical circumstances. Luckily these standards improved again in 2021. The positive COVID-19 status itself did not have a direct impact on mortality. Strikingly, none of the 33 surgically treated COVID positive patients during both years died postoperatively. This is an interesting finding which, if confirmed through future research with a larger sample size of COVID-19 positive patients, can expedite the recovery phase of acute surgical services. |
format |
article |
author |
H. Guadalajara J. L. Muñoz de Nova M. Yiasemidou M. Recarte Rico L. D. Juez J. García Septiem P. Galindo Jara M. García Virosta E. Lobo Martínez E. Martín-Pérez S. Fernandez Gonzalez O. Lopez-Fernandez D. García-Olmo PIACO Collaboration Group |
author_facet |
H. Guadalajara J. L. Muñoz de Nova M. Yiasemidou M. Recarte Rico L. D. Juez J. García Septiem P. Galindo Jara M. García Virosta E. Lobo Martínez E. Martín-Pérez S. Fernandez Gonzalez O. Lopez-Fernandez D. García-Olmo PIACO Collaboration Group |
author_sort |
H. Guadalajara |
title |
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
title_short |
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
title_full |
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
title_fullStr |
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
title_full_unstemmed |
The SARS-CoV-2 first wave impact in the acute inflammatory surgical pathologies |
title_sort |
sars-cov-2 first wave impact in the acute inflammatory surgical pathologies |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/2d7e36ab7e294d74a8f63bb837397e85 |
work_keys_str_mv |
AT hguadalajara thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT jlmunozdenova thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT myiasemidou thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT mrecarterico thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT ldjuez thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT jgarciaseptiem thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT pgalindojara thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT mgarciavirosta thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT elobomartinez thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT emartinperez thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT sfernandezgonzalez thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT olopezfernandez thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT dgarciaolmo thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT piacocollaborationgroup thesarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT hguadalajara sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT jlmunozdenova sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT myiasemidou sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT mrecarterico sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT ldjuez sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT jgarciaseptiem sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT pgalindojara sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT mgarciavirosta sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT elobomartinez sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT emartinperez sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT sfernandezgonzalez sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT olopezfernandez sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT dgarciaolmo sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies AT piacocollaborationgroup sarscov2firstwaveimpactintheacuteinflammatorysurgicalpathologies |
_version_ |
1718377788480684032 |